Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of SHR-1905 in chronic rhinosinusitis with nasal polyps
CTR20253269Phase 3Active
- Sponsor
- Hengrui Therapeutics
- Start
- Oct 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SHR-1905 in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Hengrui Therapeutics. Started Oct 2025; status: active.
02
Drugs
SHR-1905
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20253269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253269.